SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-009876
Filing Date
2022-03-11
Accepted
2022-03-11 16:44:51
Documents
12
Period of Report
2022-03-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K adpt-8k_20220309.htm   iXBRL 8-K 37707
  Complete submission text file 0001564590-22-009876.txt   163472

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA adpt-20220309.xsd EX-101.SCH 5721
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20220309_lab.xml EX-101.LAB 18672
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20220309_pre.xml EX-101.PRE 11148
6 EXTRACTED XBRL INSTANCE DOCUMENT adpt-8k_20220309_htm.xml XML 3436
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38957 | Film No.: 22733741
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences